Companies:
49,639
Total Market Cap:
134075441934734.49
Global Rank
#24409
Country Rank
#93
Market Cap
100.31 M
Price
1.17
Change (%)
2.11%
Volume
253,507
Nanoform Finland Oyj's latest marketcap:
100.31 M
As of 06/18/2025, Nanoform Finland Oyj's market capitalization has reached $100.31 M. According to our data, Nanoform Finland Oyj is the 24409th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 100.31 M |
| Revenue (ttm) | 4.53 M |
| Net Income (ttm) | -25,088,610.82 |
| Shares Out | 85.53 M |
| EPS (ttm) | -0.29 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 05/20/2025 |
Market Cap Chart
Data Updated: 06/18/2025
Nanoform Finland Oyj's yearly market capitalization.
Nanoform Finland Oyj has seen its market value drop from €471.53 M to €100.31 M since 2020, representing a total decrease of 78.73% and an annual compound decline rate (CAGR) of 29.29%.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/18/2025 | €100.31 M | -26.51% | 24409 |
| 12/30/2024 | €118.72 M | -4.5% | 21943 |
| 12/29/2023 | €124.32 M | -50.42% | 21088 |
| 12/30/2022 | €250.76 M | -47.46% | 16268 |
| 12/30/2021 | €477.28 M | 1.22% | 12819 |
| 12/30/2020 | €471.53 M | 10852 |
Company Profile
About Nanoform Finland Oyj
Nanoform Finland Oyj is a leading provider of nanotechnology and drug particle engineering services, catering to the pharmaceutical and biotech industries across Europe and the United States.
Key Services & Technologies
- Nanoforming Technologies: Specializes in transforming active pharmaceutical ingredients (API) into nanoparticles directly from solution using proprietary methods.
- Controlled Expansion of Supercritical Solutions (CESS): A cutting-edge technology for nanoparticle creation.
- Biological Nanoforming: Tailored solutions for biotech applications.
- Flexible Dosage Forms: Enables customized drug substance formulations.
- STARMAP Platform: An online tool to evaluate and select optimal candidate molecules for nanoforming.
Company Background
Founded in 2008, Nanoform Finland Oyj is headquartered in Helsinki, Finland, and continues to innovate in drug development and delivery solutions.
Frequently Asked Questions
-
What is Nanoform Finland Oyj's (HEL-NANOFH) current market cap?As of 06/18/2025, Nanoform Finland Oyj (including the parent company, if applicable) has an estimated market capitalization of $100.31 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Nanoform Finland Oyj (HEL-NANOFH) rank globally by market cap?Nanoform Finland Oyj global market capitalization ranking is approximately 24409 as of 06/18/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.